DEXTERRA GROUP INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.9 CAD | +1.72% |
|
0.00% | +2.43% |
| Mar. 11 | National Bank Revises 2024, 2025 Estimates for Dexterra Group Following Q4 Results | MT |
| Mar. 11 | Dexterra Upgraded to Outperform at Raymond James | MT |
Valuation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 421 | 559.6 | 360.8 | 371.8 | 378.5 | - |
| Enterprise Value (EV) 1 | 532.5 | 650 | 482.9 | 489.1 | 472.2 | 436 |
| P/E ratio | 5.23 x | 23.2 x | 111 x | 14 x | 11.2 x | 9.47 x |
| Yield | 2.31% | 3.78% | 6.33% | 6.08% | 5.93% | 5.93% |
| Capitalization / Revenue | 0.88 x | 0.76 x | 0.37 x | 0.33 x | 0.33 x | 0.33 x |
| EV / Revenue | 1.11 x | 0.89 x | 0.5 x | 0.44 x | 0.41 x | 0.38 x |
| EV / EBITDA | 7.49 x | 8.05 x | 7.46 x | 4.86 x | 4.74 x | 4.13 x |
| EV / FCF | 7.68 x | 11.1 x | 8.46 x | 8.15 x | 8.71 x | 6.45 x |
| FCF Yield | 13% | 9.02% | 11.8% | 12.3% | 11.5% | 15.5% |
| Price to Book | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 64,869 | 65,151 | 65,242 | 64,551 | 64,147 | - |
| Reference price 2 | 6.490 | 8.590 | 5.530 | 5.760 | 5.900 | 5.900 |
| Announcement Date | 3/10/21 | 3/9/22 | 3/8/23 | 3/7/24 | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 477.8 | 733.4 | 971.5 | 1,117 | 1,163 | 1,161 |
| EBITDA 1 | 71.09 | 80.76 | 64.72 | 100.6 | 99.68 | 105.5 |
| EBIT 1 | 50.75 | 35.96 | 10.15 | 47.55 | 56.08 | 67.89 |
| Operating Margin | 10.62% | 4.9% | 1.04% | 4.26% | 4.82% | 5.85% |
| Earnings before Tax (EBT) 1 | 76.69 | 33.34 | 3.22 | 35.24 | 42.69 | 64.7 |
| Net income 1 | 64.03 | 24.36 | 3.715 | 26.62 | 33.39 | 41.71 |
| Net margin | 13.4% | 3.32% | 0.38% | 2.38% | 2.87% | 3.59% |
| EPS 2 | 1.240 | 0.3700 | 0.0500 | 0.4100 | 0.5250 | 0.6233 |
| Free Cash Flow 1 | 69.34 | 58.63 | 57.05 | 59.98 | 54.21 | 67.56 |
| FCF margin | 14.51% | 7.99% | 5.87% | 5.37% | 4.66% | 5.82% |
| FCF Conversion (EBITDA) | 97.55% | 72.6% | 88.14% | 59.61% | 54.38% | 64.03% |
| FCF Conversion (Net income) | 108.3% | 240.71% | 1,535.69% | 225.36% | 162.37% | 161.98% |
| Dividend per Share 2 | 0.1500 | 0.3250 | 0.3500 | 0.3500 | 0.3500 | 0.3500 |
| Announcement Date | 3/10/21 | 3/9/22 | 3/8/23 | 3/7/24 | - | - |
1CAD in Million2CAD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 202.8 | 201.6 | 224 | 233.9 | 259.8 | 253.9 | 268.1 | 267.8 | 310.8 | 270.5 | 274.1 | 288.4 | 306.1 | 292.4 | 295 |
| EBITDA 1 | 22.37 | 18.05 | 17.02 | 13.64 | 20.08 | 13.99 | 21.14 | 27.22 | 39.63 | 12.64 | 21.61 | 22.43 | 28.85 | 26.85 | 24.2 |
| EBIT 1 | 11.46 | 6.069 | 2.416 | 1.932 | 9.027 | -3.227 | 8.669 | 14.96 | 22.38 | 1.545 | 8.5 | 13 | 16.8 | 16.3 | - |
| Operating Margin | 5.65% | 3.01% | 1.08% | 0.83% | 3.47% | -1.27% | 3.23% | 5.59% | 7.2% | 0.57% | 3.1% | 4.51% | 5.49% | 5.57% | - |
| Earnings before Tax (EBT) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net income 1 | 7.764 | 4.092 | 0.894 | 0.35 | 5.176 | -2.872 | 4.682 | 8.376 | 13.87 | -0.301 | 4.745 | 6.055 | 10.16 | 10.56 | 8.126 |
| Net margin | 3.83% | 2.03% | 0.4% | 0.15% | 1.99% | -1.13% | 1.75% | 3.13% | 4.46% | -0.11% | 1.73% | 2.1% | 3.32% | 3.61% | 2.75% |
| EPS 2 | 0.1200 | 0.0600 | 0.0100 | - | 0.0800 | -0.0400 | 0.0700 | 0.1300 | 0.2100 | - | 0.0820 | 0.1175 | 0.1825 | 0.1475 | 0.1350 |
| Dividend per Share 2 | 0.0875 | 0.0750 | 0.0875 | 0.0875 | 0.0875 | 0.0875 | 0.0875 | 0.0875 | - | 0.0875 | 0.0900 | 0.0900 | 0.0900 | 0.0900 | - |
| Announcement Date | 11/9/21 | 3/9/22 | 5/10/22 | 8/9/22 | 11/8/22 | 3/8/23 | 5/9/23 | 8/8/23 | 11/7/23 | 3/7/24 | - | - | - | - | - |
1CAD in Million2CAD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 111 | 90.4 | 122 | 117 | 93.7 | 57.5 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.568 x | 1.119 x | 1.887 x | 1.166 x | 0.9403 x | 0.5453 x |
| Free Cash Flow 1 | 69.3 | 58.6 | 57.1 | 60 | 54.2 | 67.6 |
| ROE (net income / shareholders' equity) | 15.3% | 8.07% | 1.26% | 9.28% | 11.6% | 11.1% |
| ROA (Net income/ Total Assets) | 9.81% | 4.66% | 0.65% | 4.37% | 6.7% | 7.6% |
| Assets 1 | 652.5 | 522.5 | 572.5 | 609.2 | 498.3 | 548.8 |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share 2 | 1.420 | 0.9900 | 0.9800 | 1.240 | 1.230 | 1.290 |
| Capex 1 | 3.46 | 5.86 | 6.94 | 20.6 | 12 | 10.6 |
| Capex / Sales | 0.72% | 0.8% | 0.71% | 1.84% | 1.03% | 0.91% |
| Announcement Date | 3/10/21 | 3/9/22 | 3/8/23 | 3/7/24 | - | - |
1CAD in Million2CAD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
5.9
CAD
Average target price
7.75
CAD
Spread / Average Target
+31.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +2.43% | 276M | |
| +6.80% | 69.42B | |
| +11.00% | 50.54B | |
| +13.31% | 16.25B | |
| +16.03% | 15.31B | |
| +22.20% | 11.17B | |
| +29.70% | 9.7B | |
| +11.86% | 5.05B | |
| +10.35% | 4.64B | |
| +23.03% | 3.79B |
- Stock Market
- Equities
- DXT Stock
- Financials Dexterra Group Inc.
